Soleus Capital
Healthcare investment firmGreenwich, United StatesSee on the mapsoleuscapital.com
Health specialist
Soleus Capital is a healthcare investment firm focused on life sciences, including biotech, medtech, diagnostics, and genomics. It invests in companies from developmental through commercial stages.
- 2
- Portfolio companies on reccy
- 1
- Hiring now
- 21
- Open roles in the portfolio
- Aug 2025
- Latest portfolio round
Hiring now in the portfolio21
Apply on each company's site- Posted 1d ago
Associate Therapy Consultant - Fresno
NeuroPace · Fresno, California
- Posted 2d ago
Associate Therapy Consultant - Birmingham
NeuroPace · Birmingham, AL
- Posted 3d ago
Associate Therapy Consultant - San Francisco Bay Area
NeuroPace · San Francisco, CA
- Posted 4d ago
Associate Therapy Consultant - Fort Worth
NeuroPace · Fort Worth, Texas
- Posted 5d ago
Associate Therapy Consultant - Charleston
NeuroPace · Charleston, South Carolina
- Posted 9d ago
Therapy Consultant - Detroit
NeuroPace · Detroit, Michigan
- Posted 9d ago
Associate Therapy Consultant - Indianapolis
NeuroPace · Indianapolis, IN
- Posted 9d ago
Associate Therapy Consultant - Grand Rapids
NeuroPace · Grand Rapids, Michigan
Portfolio on reccy2
From company funding recordsTheir companies, round by round
From company funding records- NeuroPaceMountain View, CA
EEG and neural monitoring · Neuromodulation
- Aug 2025Grant · $6.8M
- Jun 2025Post-IPO Debt · $75M
- Feb 2025Post-IPO Equity · $74.8M
- Jun 2021Grant · $9.3M
- Aug 2020Convertible Note · $34M
- Aug 2020Venture Round · $33MLed
- Longeviti Neuro SolutionsBaltimore, Maryland
EEG and neural monitoring
- Jun 2026Grant · $1M
- Aug 2025Venture Round · $10MLed
- Jan 2025Venture Round · $1.2M
- Nov 2023Venture Round · $750K
- May 2023Venture Round · $1.2M
- Jan 2022Venture Round · $4.8M
Rounds marked Led list Soleus Capital as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Aug 2025
Longeviti Neuro Solutions · Venture Round $10MLead
- Aug 2020
NeuroPace · Venture Round $33MLead
With Accelmed Partners II LP, Accelmed Partners, KCK, KCK Group, Johnson & Johnson Development Corporation, Revelation Partners, OrbiMed Advisors
- Aug 2020
NeuroPace · Series E $4.6MLead